LH · News · 20260805N
Revenue Performance and Mix
LABCORP HOLDINGS INC. · 2026-08-05 · Importance 43 · Surprise 32
Labcorp’s Q2 2026 enterprise revenue increased 5.8% year over year to approximately $3.7 billion, or $3,731.1 million. Diagnostics Laboratories and Biopharma Laboratory Services both delivered significant growth during the quarter. Revenue growth was attributed to increased test utilization, specialty testing, price/mix gains, strategic partnerships, and operational efficiencies.
Key facts
- Q2 2026 revenue was US$3,731.1 million. source